The AIIMS Rishikesh study will also evaluate the effects of pranayama in patients with moderate symptoms.
The Department of Science and Technology (DST) conducted a clinical trial at the All India Institute of Medical Sciences (AIIMS) in Rishikesh to determine whether chanting of the Gayatri Mantra, a religious hymn, and yoga practice of Pranayama, a subset of patients May help to recover COVID-19 as well as the quality of recovery.
Clinical trials are formally registered with the Indian Council of Medical Research (ICMR) Clinical Trials Registry (A mandatory requirement for human trials), aiming to recruit 20 COVID-19 patients with “moderate symptoms”. Divided into two groups, one will receive standard treatment and the other, with standard treatment, will be subject to chanting and breathing exercises for 14 days to be supervised by a certified yoga instructor.
Editorial | Scientific apathy: On the presence of the Minister of Health in the coronil promotion program
The groups will then be compared based on whether those who have received additional treatment show on average better markers for inflammation or cell-injury. Among the causes of severe COVID-19 is an exaggerated response by the body’s immune system to the presence of the virus, which leads to severe cellular inflammation and damage that may prove fatal. While many experimental treatments exist, no specific medicine has been proven to improve health outcomes.
The latest study, however, will not test the effect of the intervention on critically ill patients. It will evaluate whether there are differences in groups over time to test negative, and the length of their hospital stay.
They will also be evaluated on whether they have reduced fatigue and anxiety disorder. Pulmonologist and Associate Professor at AIIMS Drs. Ruchi Dua told Hindu Recruitment for the study had already started. “The institute also includes a postdoctoral researcher doing research on yoga. We will measure markers of inflammation through a standard scale to measure C-reactive protein levels as well as health outcomes over the next two-three months, ”she said Hindu In a phone conversation.
Read this also. In the race of ‘immunity’, Ayurveda supplementation is an untouched run
It applied for funds from DST in response to an open call to fund for projects to develop COVID-19 relevant medicine, drugs and interventions. She has been funded with ₹ 3 lakh to study.
Along with medicines and vaccines, India’s COVID-19 treatment strategy also includes Ayurveda and yoga that are asymptomatic or that manifest mild symptoms of the disease. Other Ayurvedic interventions, such as coronil by Patanjali, have also been purified as “cures” for COVID-19, but are based on small groups of patients with milder forms of the disease, which, as experience suggests, may be associated with a specific intervention. They recover without it.
DST has also previously conducted funded studies that evaluate the effects of yoga or alternative medicine in the management of the disease.
.
Leave a Reply